Karel Horký

Summary

Affiliation: Charles University
Country: Czech Republic

Publications

  1. ncbi request reprint [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management]
    K Horky
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 57:1012-6. 2011
  2. ncbi request reprint [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]
    K Horky
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 53:364-70. 2007
  3. ncbi request reprint [Reducing food salt content--a neglected approach to hypertension prevention and treatment in the population]
    K Horky
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 55:797-801. 2009
  4. ncbi request reprint [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases]
    Karel Horký
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 56:120-6. 2010
  5. ncbi request reprint Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men
    Ales Linhart
    2nd Department of Internal Medicine, 1st School of Medicine, Charles University, Prague, Czech Republic
    Br J Biomed Sci 59:90-4. 2002
  6. ncbi request reprint Association of -344/T/C aldosterone synthase polymorphism (CYP11B2) with left ventricular structure and humoral parameters in young normotensive men
    Samuel Heller
    2nd Department of Internal Medicine, 1st School of Medicine, Charles University, Prague, Czech Republic
    Blood Press 13:158-63. 2004
  7. ncbi request reprint Antonín vancura and arterial hypertension. 50 years' evolution in the conception of pathogenesis and treatment of the disease
    Karel Horký
    2nd Department of Medicine, Charles University 1st School of Medicine and University General Hospital, Prague, Czech Republic
    Kidney Blood Press Res 29:237-42. 2006

Detail Information

Publications7

  1. ncbi request reprint [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management]
    K Horky
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 57:1012-6. 2011
    ....
  2. ncbi request reprint [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]
    K Horky
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 53:364-70. 2007
    ....
  3. ncbi request reprint [Reducing food salt content--a neglected approach to hypertension prevention and treatment in the population]
    K Horky
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 55:797-801. 2009
    ....
  4. ncbi request reprint [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases]
    Karel Horký
    II interní klinika kardiologie a angiologie 1 lékarské fakulty UK a VFN Praha
    Vnitr Lek 56:120-6. 2010
    ....
  5. ncbi request reprint Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men
    Ales Linhart
    2nd Department of Internal Medicine, 1st School of Medicine, Charles University, Prague, Czech Republic
    Br J Biomed Sci 59:90-4. 2002
    ....
  6. ncbi request reprint Association of -344/T/C aldosterone synthase polymorphism (CYP11B2) with left ventricular structure and humoral parameters in young normotensive men
    Samuel Heller
    2nd Department of Internal Medicine, 1st School of Medicine, Charles University, Prague, Czech Republic
    Blood Press 13:158-63. 2004
    ..We assessed the influence of the T-344C polymorphism of aldosterone synthase - the rate-limiting enzyme in aldosterone biosynthesis - on the structure of the left ventricle in young normotensive men...
  7. ncbi request reprint Antonín vancura and arterial hypertension. 50 years' evolution in the conception of pathogenesis and treatment of the disease
    Karel Horký
    2nd Department of Medicine, Charles University 1st School of Medicine and University General Hospital, Prague, Czech Republic
    Kidney Blood Press Res 29:237-42. 2006
    ..In many ways, Vancura outstripped his time and his concepts approached today's standings and so founded one of the important schools of hypertension in Czechoslovakia and Europe...